Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

BACKGROUND: Immune checkpoint inhibitors (ICIs) have achieved unprecedented success in cancer treatment over the past decade. The application of ICIs hasled to the discovery of various types of immune-related adverse events (irAEs). Here, we report a case of fatal myositis and spontaneous haematoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuan, Liu, Zhi, Zeng, Xuejun, Bai, Chunmei, Chen, Lin, Lin, Songbai, Tian, Xinlun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896742/
https://www.ncbi.nlm.nih.gov/pubmed/31805889
http://dx.doi.org/10.1186/s12885-019-6372-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896742/
https://www.ncbi.nlm.nih.gov/pubmed/31805889
http://dx.doi.org/10.1186/s12885-019-6372-z

Ejemplares similares